Extendicare Financials

EXE Stock  CAD 13.05  0.07  0.54%   
You can exercise fundamental analysis to find out if Extendicare is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to analyze and collect data for thirty-eight available fundamental indicators for Extendicare, which can be compared to its peers. The stock experiences a moderate upward volatility. Check odds of Extendicare to be traded at C$14.36 in 90 days. Key indicators impacting Extendicare's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income94 M111.2 M
Fairly Down
Slightly volatile
Current Ratio1.050.8321
Significantly Up
Pretty Stable
  
Understanding current and past Extendicare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Extendicare's financial statements are interrelated, with each one affecting the others. For example, an increase in Extendicare's assets may result in an increase in income on the income statement.

Extendicare Stock Summary

Extendicare competes with Sienna Senior, Chartwell Retirement, Chemtrade Logistics, NorthWest Healthcare, and Exchange Income. Extendicare Inc. provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. EXTENDICARE INC operates under Medical Care Facilities classification in Canada and is traded on Toronto Stock Exchange. It employs 22800 people.
Foreign Associate
  USA
Specialization
Health Care, Health Care Equipment & Services
InstrumentCanada Stock View All
ExchangeToronto Exchange
ISINCA30224T8639
Business Address3000 Steeles Avenue
SectorHealth Care Providers & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.extendicare.com
Phone905 470 4000
CurrencyCAD - Canadian Dollar
You should never invest in Extendicare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Extendicare Stock, because this is throwing your money away. Analyzing the key information contained in Extendicare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Extendicare Key Financial Ratios

Extendicare's financial ratios allow both analysts and investors to convert raw data from Extendicare's financial statements into concise, actionable information that can be used to evaluate the performance of Extendicare over time and compare it to other companies across industries.

Extendicare Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets963.1M900.3M781.6M672.7M719.8M1.1B
Other Current Liab23.4M16.1M7.9M6.2M5.6M5.3M
Net Debt384.6M432.2M216.7M259.3M170.6M162.1M
Accounts Payable168.0M189.1M242.2M197.1M241.5M145.9M
Net Receivables73.4M83.5M64.1M91.0M88.7M125.6M
Other Current Assets40.2M26.5M24.0M20.2M28.8M47.0M
Total Liab834.9M798.4M680.9M584.8M595.4M988.6M
Total Current Assets296.1M224.9M258.0M187.1M243.7M273.8M
Short Term Debt71.4M73.6M19.2M19.9M22.9M21.7M
Intangible Assets36.5M46.6M51.2M78.5M75.1M38.2M
Retained Earnings(371.0M)(402.5M)(384.6M)(393.5M)(352.5M)(370.2M)
Cash180.0M104.6M167.3M75.2M121.8M105.1M
Common Stock500.6M500.9M475.4M467.3M537.4M534.0M
Other Liab74.3M59.6M52.5M41.2M37.0M35.2M
Net Tangible Assets25.5M40.0M9.4M3.6M4.2M4.0M
Other Assets53.0M47.3M37.8M1.00.90.86
Long Term Debt493.2M463.3M364.7M314.6M261.4M360.1M
Short Long Term Debt71.4M73.6M19.2M19.9M31.1M29.5M
Long Term Debt Total422.5M493.2M463.3M364.7M328.3M355.2M
Capital Surpluse3.7M4.9M8.2M10.6M12.2M12.8M

Extendicare Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense28.5M27.2M20.6M21.6M22.1M21.0M
Total Revenue1.2B1.2B1.2B1.3B1.5B1.3B
Gross Profit197.7M151.7M76.8M118.4M106.6M101.3M
Operating Income93.3M56.6M21.0M111.8M111.2M94.0M
Ebit87.0M36.4M17.2M66.4M59.7M87.6M
Ebitda125.1M67.5M48.9M98.6M88.8M133.1M
Income Before Tax58.9M16.0M(4.5M)44.8M99.9M104.9M
Net Income42.6M9.0M(4.5M)34.0M75.2M79.0M
Income Tax Expense16.3M7.0M15K10.8M9.7M10.5M
Cost Of Revenue960.6M1.1B1.1B1.2B1.1B1.1B
Tax Provision16.3M7.0M15K10.8M24.7M25.9M
Interest Income29.0M23.7M15.5M6.2M7.0M6.7M
Extraordinary Items11.6M11.6M2.5M74.1M66.7M70.0M
Net Interest Income(27.0M)(25.0M)(15.3M)(15.5M)(15.7M)(16.5M)

Extendicare Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash85.5M(75.3M)62.7M(92.1M)46.7M49.0M
Free Cash Flow88.2M(6.1M)(2.9M)(106.1M)101.7M106.8M
Depreciation38.8M38.6M32.1M32.6M33.3M45.1M
Other Non Cash Items(12.3M)(10.5M)(59.6M)(10.3M)18.4M16.8M
Capital Expenditures33.1M69.5M101.6M129.4M42.0M51.0M
Net Income54.2M11.5M69.6M34.0M75.2M79.0M
End Period Cash Flow180.0M104.6M167.3M75.2M121.8M100.8M
Dividends Paid41.3M43.0M42.6M40.4M(40.0M)(38.0M)
Net Borrowings10.3M7.0M(30.0M)(114.2M)(102.8M)(97.7M)
Change To Netincome(19.3M)6.2M(283K)(57.0M)(51.3M)(48.8M)
Investments2.0M(63.7M)155.6M(84.5M)(9.1M)(9.6M)

Extendicare Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Extendicare's current stock value. Our valuation model uses many indicators to compare Extendicare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Extendicare competition to find correlations between indicators driving Extendicare's intrinsic value. More Info.
Extendicare is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.14  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Extendicare is roughly  7.10 . At this time, Extendicare's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Extendicare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Extendicare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Extendicare Systematic Risk

Extendicare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Extendicare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Extendicare correlated with the market. If Beta is less than 0 Extendicare generally moves in the opposite direction as compared to the market. If Extendicare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Extendicare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Extendicare is generally in the same direction as the market. If Beta > 1 Extendicare moves generally in the same direction as, but more than the movement of the benchmark.

Extendicare Total Assets Over Time

Extendicare Thematic Clasifications

Extendicare is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
HealthcareView
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Extendicare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Extendicare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Extendicare growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.12

At this time, Extendicare's Price Earnings To Growth Ratio is very stable compared to the past year.

Extendicare March 20, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Extendicare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Extendicare. We use our internally-developed statistical techniques to arrive at the intrinsic value of Extendicare based on widely used predictive technical indicators. In general, we focus on analyzing Extendicare Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Extendicare's daily price indicators and compare them against related drivers.

Other Information on Investing in Extendicare Stock

Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.